Nervgen Pharma NGEN Estimates

NASDAQ NGEN
$1.92 +0.00 (+0.01%)
As of: Sep 30, 2026 · 1:27 PM EDT
Analyst Estimates

Nervgen Pharma Corp. Annual Revenue Estimates

Periods 6
Next Period 2026
Consensus 0.00

Analysts expect Nervgen Pharma Corp. to report revenue of 0.00 for 2026, against a range of 0.00 to 0.00. The most recent reported year, 2025, came in at 0.00.

Metric 202420252026202720282029
Reported (Actual) 0.000.00--
High Estimate 0.000.000.000.00
Low Estimate 0.000.000.000.00
Consensus Estimate 0.000.000.000.00
Analyst Estimates

Nervgen Pharma Corp. Earnings Per Share (EPS) Estimates

Periods 26
Next Period Q3 26
Consensus -0.10

Analysts expect Nervgen Pharma Corp. to report earnings per share of -0.10 for Q3 26, against a range of -0.10 to -0.10. The most recent reported quarter, Q2 26, came in at -0.27, a 350.0% miss against the -0.06 consensus.

Metric Q3 24Q4 24Q1 25Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26Q1 27Q2 27Q3 27Q4 27Q1 28Q2 28Q3 28Q4 28Q1 29Q2 29Q3 29Q4 29Q1 30Q2 30Q3 30Q4 30
Reported (Actual) -0.05-0.10-0.04-0.09-0.04-0.26-0.01-0.27--------
High Estimate -0.05-0.06-0.06-0.05-0.06-0.05-0.07-0.05-0.10-0.10-0.09-0.09-0.06-0.12-0.07-0.13
Low Estimate -0.05-0.06-0.06-0.05-0.06-0.07-0.07-0.07-0.10-0.12-0.09-0.11-0.06-0.14-0.07-0.15
Consensus Estimate -0.05-0.06-0.06-0.05-0.06-0.06-0.07-0.06-0.10-0.11-0.09-0.10-0.06-0.13-0.07-0.14

Nervgen Pharma Corp. Estimates API

Pull Wall Street consensus for Nervgen Pharma Corp. (high, low and consensus estimates alongside reported actuals) into your own models and apps with the Business Quant Estimates API. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/estimates?ticker=NGEN&mode=revenue&api_key=YOUR_API_KEY